Sarilumab reduces disease activity in rheumatoid arthritis patients with inadequate response to janus kinase inhibitors or tocilizumab in regular care in Germany

por Tony, Hans-Peter, Feist, Eugen, Aries, Peer Malte, Zinke, Silke, Krüger, Klaus, Ahlers, Jonas, Albrecht, Inka, Barrionuevo, Christian, Kalus, Stefanie, Burkhardt, Harald
Publicado 2022

Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI)

por Straňák, Zbyněk, Saliba, Elie, Kosma, Paraskevi, Posfay-Barbe, Klara, Yunis, Khalid, Farstad, Teresa, Unnebrink, Kristina, van Wyk, Jean, Wegzyn, Colleen, Notario, Gerard, Kalus, Stefanie, Campbell, Fiona J.
Publicado 2016

Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry

por Maggioni, Aldo P., Clark, Andrew L., Barrios, Vivencio, Damy, Thibaud, Drozdz, Jaroslaw, Fonseca, Candida, Lund, Lars H., Kalus, Stefanie, Ferber, Philippe C., Hussain, Rizwan I., Koch, Cornelia, Zeymer, Uwe
Publicado 2022